Seegene Inc.
Seegene tirelessly pursues innovation and takes on new challenges to build a better future for humanity. Seegene has developed instruments for molecular diagnostics based on OEM partnership. In addition to that, Seegene has developed its own automation system including DNA extraction, PCR reagent dispenser, auto electrophoresis, POCT, Real-time PCR, decapper and much more for any necessary supplements for molecular diagnosis. Seegene has established global sales networks covering more than 60 countries around the world, and 6 overseas subsidiaries in North and South America, Europe and the Middle East that drive and support Seegene’s global business operation. Seegene strives to satisfy customers in all these regions by listening and responding to their needs enthusiastically in a timely manner.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Equipment
- Market Focus:
- Globally (various continents)
About us
Seegene aims to bring a healthy life for everyone by creating a new diagnostics paradigm
- MDx technology
Wide range of solutions applicable in diverse markets from clinical diagnostics to basic science research
- IT convergence technology
Rapid development of innovative diagnostic products and automated software using IT technology based on extensive expertise in developing diagnostic reagents
- Automated instrumentation
Deliver clinically useful results fast and accurately for both patients and clinicians with an automated platform
- Test platform solution
Develops an optimized MDx platform that enables to provide MDx services at affordable price in any size of hospitals
- DPO™ Technology
for multiple target amplification
- TOCE™ Technology
for multiple target detection
- MuDT™ Technology
for multiple target real-time analysis
- Simultaneous detection
Early diagnosis of multiple infections (co-infections by more than one causal pathogen), allowing appropriatetreatment to be applied for each causal pathogen.
- Precise diagnosis
Confirm certainty of infection as well as measure severity based on quantitative information of infection, supporting healthcare providers in tracking/responding to patient’s condition.
- Timely diagnosis
Detect multiple causal pathogens in a single test, allowing appropriate treatment regimens in the early stage.
- Affordable diagnosis
Cost-effective tests not only improve patient management but also relieve financial burden of healthcare system.
Seegene has produced and delivered molecular diagnostics (MDx) products capable of detecting multiple targets simultaneously.
Seegene’s high multiplex assays deliver comprehensive clinical information in a single test and allow accurate and rapid diagnosis.